| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $38.5M | +9.6% |
| Cost of Revenue | $4K | -95.5% |
| R&D Expense | $1.4M | -66.7% |
| SG&A Expense | $11.4M | +16.3% |
| Operating Income | $24.4M | +37.4% |
| Pre-tax Income | $27.0M | +56.0% |
| Income Tax | -$3.7M | -177.0% |
| Net Income | $30.7M | +145.6% |
| EPS (Basic) | $0.92 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $48.8M | -5.2% |
| Short-term Investments | $100.9M | +16.8% |
| Accounts Receivable | $1.0M | -18.8% |
| Current Assets | $160.3M | +4.6% |
| Total Assets | $190.1M | +8.3% |
| Current Liabilities | $19.3M | +16.3% |
| Total Liabilities | $32.4M | -5.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $40.1M | +130.1% |
| Capital Expenditures | $30K | -91.0% |
| Investing Cash Flow | -$29.4M | +66.5% |
| Financing Cash Flow | -$13.4M | -121.6% |
| Free Cash Flow | $40.1M | +134.4% |
| +130.0% |
| EPS (Diluted) | $0.92 | +135.9% |
| Stockholders' Equity |
| $157.7M |
| +11.6% |